Literature DB >> 8386830

Expression of nm23/NDP kinase proteins on the cell surface.

T Urano1, K Furukawa, H Shiku.   

Abstract

We determined whether proteins encoded by the nm23/nucleoside diphosphate (NDP) kinase gene, a potential metastasis-suppressor gene, are expressed on the cell surface. Monoclonal antibodies (mAb) specific for nm23-H1 or H2 proteins were prepared using the corresponding fusion proteins with glutathione S-transferase (GST) as immunogens. mAb H1-229 was specifically reactive with nm23-H1 protein, whereas mAb H2-439 was specific for nm23-H2 protein in immunoprecipitation and immunoblotting. mAb H1-229 was reactive with most human hematopoietic and some non-hematopoietic cell lines in flow cytometry. On the other hand, mAb H2-439 was reactive with only a limited number of cell lines. Based upon the surface expression of nm23/NDP kinase, cells were classified as nm23-H1+H2-, nm23-H1+H2+ or nm23-H1-H2-. No cell lines with nm23-H1-H2+ were found among those examined. The specificity of flow cytometry analysis was confirmed in the murine myeloma line NS-1 transfected with either the nm23-H1 or H2 genes. Both mAbs were reactive only to NS-1 transfected with the corresponding nm23 genes. Immunoprecipitation and SDS-PAGE analysis identified 20.5- and 18-kDa proteins with mAb H1-229 or H2-439, respectively, in cellular extracts of 125I-surface labeled NS-1 transfected with the corresponding genes. The presence of nm23/NDP kinase on the cell surface indicates an extracellular role for these proteins in addition to their reported intracellular functions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386830

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  NM23 protein in neoplastic and nonneoplastic thyroid tissues.

Authors:  P Bertheau; A De La Rosa; P S Steeg; M J Merino
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

Review 2.  Physiological and pathological relevance of extracellular NM23/NDP kinases.

Authors:  Junko Okabe-Kado; Takashi Kasukabe
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

3.  Expression of nm23-H1 gene product in thyroid, ovary, and breast cancers.

Authors:  T Okubo; S Inokuma; S Takeda; S Itoyama; K Kinoshita; I Sugawara
Journal:  Cell Biophys       Date:  1995-06

4.  Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production.

Authors:  Junko Okabe-Kado; Takashi Kasukabe; Yoshio Honma; Hirofumi Kobayashi; Nobuo Maseki; Yasuhiko Kaneko
Journal:  Int J Hematol       Date:  2009-08-05       Impact factor: 2.490

5.  Extracellular NM23 Protein as a Therapeutic Target for Hematologic Malignancies.

Authors:  Junko Okabe-Kado; Takashi Kasukabe; Yasuhiko Kaneko
Journal:  Adv Hematol       Date:  2011-09-19

6.  The association between nm23 gene expression and survival in patients with sarcomas.

Authors:  J A Royds; M H Robinson; T J Stephenson; R C Rees; C Fisher
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas.

Authors:  O Takeda; M Handa; T Uehara; N Maseki; A Sakashita; M Sakurai; N Kanda; Y Arai; Y Kaneko
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

8.  Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na(+), K(+)-ATPase.

Authors:  N lizuka; K Miyamoto; A Tangoku; H Hayashi; S Hazama; S Yoshino; K Yoshimura; K Hirose; H Yoshida; M Oka
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

9.  Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis.

Authors:  A Yamaguchi; T Urano; S Fushida; K Furukawa; G Nishimura; Y Yonemura; I Miyazaki; G Nakagawara; H Shiku
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

10.  Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma.

Authors:  J Watanabe; Y Sato; H Kuramoto; T Kameya
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.